4.6 Article

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer

Philip Sutera et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Oncology

Central liver toxicity after SBRT: An expanded analysis and predictive nomogram

Diego A. S. Toesca et al.

RADIOTHERAPY AND ONCOLOGY (2017)

Article Oncology

Predictors of Toxicity Associated With Stereotactic Body Radiation Therapy to the Central Hepatobiliary Tract

Evan C. Osmundson et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)

Article Oncology

DESCRIPTIVE ANALYSIS OF OLIGOMETASTATIC LESIONS TREATED WITH CURATIVE-INTENT STEREOTACTIC BODY RADIOTHERAPY

Michael T. Milano et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)